摘要 |
The invention provides a compound of the general formula (I) wherein R<1> is selected from hydrogen, cycloalkyl and cycloalkenyl having 3 to 7 ring members; phenyl-C1-4 alkyl or a group R<4>-A-CH2-, R<2> is selected from aryl and heteroaryl having five to twelve ring members; cycloalkyl and cycloalkenyl having 3 to 7 ring members; a group (CR<6>R<7>)pE-R<8>, or R<1> and R<2> together with the nitrogen atom to which they are attached form a heterocyclic group having 5 to 10 ring members; R<3> is a substituent selected from halogen, CN, N-linked monocyclic nitrogen-containing heterocyclic groups having from 3 to 7 ring members and containing up to three heteroatoms; and a group R<a>-R<b>. The substituents R<4>-R<,> R<a> and R<b> are defined in claim 1. The compounds have activity as inhibitors of cyclin dependent kinases and are useful in the treatment of disease states and conditions, such as proliferative diseases, mediated by cyclin dependent kinases. |
申请人 |
ASTEX TECHNOLOGY LIMITED;WOOLFORD, ALISON, JO-ANNE;BERDINI, VALERIO;OREILLY, MARC;PADOVA, ALESSANDRO;SAXTY, GORDON;WYATT, PAUL, GRAHAM |
发明人 |
WOOLFORD, ALISON, JO-ANNE;BERDINI, VALERIO;OREILLY, MARC;PADOVA, ALESSANDRO;SAXTY, GORDON;WYATT, PAUL, GRAHAM |